Patient-Reported Outcomes (PROs) and PRO Remission Rates in 12,262 Biologic-Naïve Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitors in Routine Care
Lykke Midtbøll Ørnbjerg*, Kathrine Rugbjerg, Stylianos Georgiadis, Simon Horskjær Rasmussen, Lennart Jacobsson, Anne Gitte Loft, Florenzo Iannone, Karen Minde Fagerli, Jiri Vencovsky, Maria José Santos, Burkhard Möller, Manuel Pombo-Suarez, Ziga Rotar, Bjorn Gudbjornsson, Ayse Cefle, Kari Eklund, Catalin Codreanu, Gareth Jones, Marleen van der Sande, Johan Karlsson WallmanMarco Sebastiani, Brigitte Michelsen, Jakub Závada, Michael John Nissen, Carlos Sanchez-Piedra, Matija Tomšič, Thorvardur Jon Love, Heikki Relas, Corina Mogosan, Merete Lund Hetland, Mikkel Østergaard
Dive into the research topics of 'Patient-Reported Outcomes (PROs) and PRO Remission Rates in 12,262 Biologic-Naïve Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitors in Routine Care'. Together they form a unique fingerprint.